ArticleBioinformation2025
Severity of diabetic retinopathy severity with renal function and body fat in type 2 diabetes mellitus: A hospital-based cross-sectional study in India.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) severity and renal impairment are important complications of type 2 diabetes mellitus. However, the relationship between them and body fat percentage (BFP) is not known. Hence, a cross-sectional study was conducted on 166 patients aged 30-70 years that measured DR severity, renal function and body fat percentage (BFP) using traditional clinical and anthropometric assessments. This data shows DR severity was related to measurable deterioration in renal parameters and raised body fat percentage (BFP). Thus, we show the understanding of the inter-relationships between microvascular and metabolic-related complications of diabetes. Increased screening earlier may help risk stratify and potentially facilitate comprehensive management of the patient in the clinical setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.